|
MYL5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.144000E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.522400E-03 |
| Normal-vs-Stage2 |
1.687450E-01 |
| Normal-vs-Stage3 |
4.762800E-01 |
| Normal-vs-Stage4 |
3.624400E-02 |
| Stage1-vs-Stage2 |
8.536400E-01 |
| Stage1-vs-Stage3 |
3.251800E-01 |
| Stage1-vs-Stage4 |
3.900600E-01 |
| Stage2-vs-Stage3 |
5.293600E-01 |
| Stage2-vs-Stage4 |
3.227800E-01 |
| Stage3-vs-Stage4 |
1.258790E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.441400E-03 |
| Normal-vs-AfricanAmerican |
8.283700E-02 |
| Normal-vs-Asian |
1.867840E-01 |
| Caucasian-vs-AfricanAmerican |
6.535400E-01 |
| Caucasian-vs-Asian |
1.816230E-01 |
| AfricanAmerican-vs-Asian |
1.349770E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.084660E-03 |
| Normal-vs-Female |
1.821040E-01 |
| Male-vs-Female |
3.278800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.415100E-03 |
| Normal-vs-Extreme_Weight |
9.057500E-03 |
| Normal-vs-Obese |
8.743900E-02 |
| Normal-vs-Extreme_Obese |
2.647600E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.159200E-01 |
| Normal_Weight-vs-Obese |
1.443990E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.332400E-01 |
| Extreme_Weight-vs-Obese |
5.446600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.940600E-01 |
| Obese-vs-Extreme_Obese |
4.843200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.954100E-02 |
| Normal-vs-Age(41-60Yrs) |
4.821800E-02 |
| Normal-vs-Age(61-80Yrs) |
3.001000E-03 |
| Normal-vs-Age(81-100Yrs) |
2.884400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.362800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.185400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.788600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.617200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.513000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.345400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.335800E-03 |
| Normal-VS-Type2 PRCC |
6.395900E-04 |
| Normal-VS-KIRP CIMP |
8.875200E-01 |
| Normal-VS-Unclassified PRCC |
5.700600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.495700E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.658600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.734800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.199770E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.534000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.871200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.935500E-02 |
| Normal-vs-N1 |
1.296240E-01 |
| Normal-vs-N2 |
5.967600E-01 |
| N0-vs-N1 |
8.219800E-01 |
| N0-vs-N2 |
3.650200E-01 |
| N1-vs-N2 |
4.176600E-01 |
|
|
